Back to search results

The Agenda-Setting for Kidney Disease Open Pilot Trial

This study is testing a new way to help people with advanced chronic kidney disease (CKD) (stages 4-5) talk with their doctors. It's called the Chronic Kidney Disease Structured Agenda-Setting Tool (CKD Topics). This tool helps you and your care team discuss important topics during your clinic visits. The study wants to see if the steps for finding participants and using CKD Topics work well before a larger study. You might be able to join if you are over 18, have advanced CKD, speak English, and attend outpatient visits. The main goal is to see if the intervention can be successfully given to participants.

Study design
This is an open pilot study with 30 participants. It has one group, and everyone in that group will receive the Chronic Kidney Disease Structured Agenda-Setting Tool.
What's involved
You would participate in outpatient visits (in-person or telehealth) where the CKD Topics tool is used. You would also complete surveys.
Compensation
Not stated in the trial record.
Follow-up
The primary feasibility outcome is measured at Day 1, which suggests a short follow-up period for this specific measure.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07221604

The Agenda-Setting for Kidney Disease Open Pilot Trial

Recruiting
NAAges 18+InterventionalHealth services
Dartmouth-Hitchcock Medical Center
~30 participants
Updated 2026-07-23 on ClinicalTrials.gov
What's tested:Chronic Kidney Disease Structured Agenda-Setting Tool

At a glance

Recruiting sites
1 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Primary Feasibility Outcome: Intervention receipt
Measured over Day 1

Conditions

Chronic Kidney Disease Stage 4

Explore related trials

Chronic Kidney Disease

NCT07221604

Where you'd take part

This study runs at 2 sites. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Cheshire Medical Center/Dartmouth-Hitchcock

    Keene, New Hampshirestudy coordinator listed

    Recruiting

  • Dartmouth Hitchcock Medical Center

    Lebanon, New Hampshireno site contact published

    Not yet recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Who to contact

Catherine H. Saunders, Assistant Professor of Medicine and of Health Policy, PhD, MPH
[email protected]
603-653-3436
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Adults \>18 years old who have been diagnosed with advanced CKD (stages 4-5).
Care partners, clinicians and staff supporting these CKD patients who are willing and able to provide informed consent
English-speaking
Able to provide informed consent
Patient must be attending outpatient visits \*(in-person and/or telehealth allowable).

Exclusion

Children under 18 years old will not be included
Non-English-speaking patients and/or care partners
Patients on dialysis
Individuals unable or unwilling to provide informed consent

What this trial measures

  • Primary Feasibility Outcome: Intervention receiptDay 1

    Our primary outcome will be feasibility, assessed by the proportion of patients who received the intervention.